nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC15A1—Lisinopril—systemic scleroderma	0.255	0.322	CbGbCtD
Cefotaxime—SLC15A1—Captopril—systemic scleroderma	0.191	0.241	CbGbCtD
Cefotaxime—SLC22A6—Captopril—systemic scleroderma	0.105	0.133	CbGbCtD
Cefotaxime—SLC22A11—Methotrexate—systemic scleroderma	0.0821	0.104	CbGbCtD
Cefotaxime—SLC22A7—Methotrexate—systemic scleroderma	0.0782	0.0986	CbGbCtD
Cefotaxime—SLC22A8—Methotrexate—systemic scleroderma	0.0477	0.0602	CbGbCtD
Cefotaxime—SLC22A6—Methotrexate—systemic scleroderma	0.0333	0.0419	CbGbCtD
Cefotaxime—Erythema multiforme—Captopril—systemic scleroderma	0.000857	0.00414	CcSEcCtD
Cefotaxime—Renal impairment—Mycophenolate mofetil—systemic scleroderma	0.000854	0.00413	CcSEcCtD
Cefotaxime—Dermatitis bullous—Mycophenolate mofetil—systemic scleroderma	0.000851	0.00411	CcSEcCtD
Cefotaxime—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00085	0.00411	CcSEcCtD
Cefotaxime—Shock—Pentoxifylline—systemic scleroderma	0.000836	0.00404	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.000836	0.00404	CcSEcCtD
Cefotaxime—Neutropenia—Mycophenolic acid—systemic scleroderma	0.000833	0.00402	CcSEcCtD
Cefotaxime—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.000832	0.00402	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.000825	0.00399	CcSEcCtD
Cefotaxime—Agranulocytosis—Azathioprine—systemic scleroderma	0.000822	0.00397	CcSEcCtD
Cefotaxime—Angioedema—Mometasone—systemic scleroderma	0.000821	0.00397	CcSEcCtD
Cefotaxime—Renal failure—Leflunomide—systemic scleroderma	0.000818	0.00395	CcSEcCtD
Cefotaxime—Jaundice—Leflunomide—systemic scleroderma	0.000811	0.00392	CcSEcCtD
Cefotaxime—Haemoglobin—Azathioprine—systemic scleroderma	0.000795	0.00384	CcSEcCtD
Cefotaxime—Eosinophilia—Lisinopril—systemic scleroderma	0.000794	0.00384	CcSEcCtD
Cefotaxime—Haemorrhage—Azathioprine—systemic scleroderma	0.000791	0.00382	CcSEcCtD
Cefotaxime—Bronchospasm—Lisinopril—systemic scleroderma	0.000789	0.00381	CcSEcCtD
Cefotaxime—Renal failure—Mycophenolic acid—systemic scleroderma	0.00078	0.00377	CcSEcCtD
Cefotaxime—Agranulocytosis—Leflunomide—systemic scleroderma	0.000777	0.00375	CcSEcCtD
Cefotaxime—Jaundice—Mycophenolic acid—systemic scleroderma	0.000774	0.00374	CcSEcCtD
Cefotaxime—Haemoglobin—Leflunomide—systemic scleroderma	0.000751	0.00363	CcSEcCtD
Cefotaxime—Neutropenia—Lisinopril—systemic scleroderma	0.00075	0.00362	CcSEcCtD
Cefotaxime—Erythema multiforme—Azathioprine—systemic scleroderma	0.000748	0.00361	CcSEcCtD
Cefotaxime—Hepatitis—Leflunomide—systemic scleroderma	0.000747	0.00361	CcSEcCtD
Cefotaxime—Haemorrhage—Leflunomide—systemic scleroderma	0.000747	0.00361	CcSEcCtD
Cefotaxime—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.000741	0.00358	CcSEcCtD
Cefotaxime—Anaphylactic shock—Mometasone—systemic scleroderma	0.000733	0.00354	CcSEcCtD
Cefotaxime—Ill-defined disorder—Captopril—systemic scleroderma	0.000732	0.00354	CcSEcCtD
Cefotaxime—Angioedema—Captopril—systemic scleroderma	0.000721	0.00348	CcSEcCtD
Cefotaxime—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.000716	0.00346	CcSEcCtD
Cefotaxime—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.000713	0.00344	CcSEcCtD
Cefotaxime—Hepatitis—Mycophenolic acid—systemic scleroderma	0.000713	0.00344	CcSEcCtD
Cefotaxime—Malaise—Captopril—systemic scleroderma	0.000712	0.00344	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000709	0.00342	CcSEcCtD
Cefotaxime—Arrhythmia—Azathioprine—systemic scleroderma	0.000707	0.00341	CcSEcCtD
Cefotaxime—Erythema multiforme—Leflunomide—systemic scleroderma	0.000706	0.00341	CcSEcCtD
Cefotaxime—Renal failure—Lisinopril—systemic scleroderma	0.000703	0.0034	CcSEcCtD
Cefotaxime—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.0007	0.00338	CcSEcCtD
Cefotaxime—Jaundice—Lisinopril—systemic scleroderma	0.000697	0.00337	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000695	0.00336	CcSEcCtD
Cefotaxime—Urticaria—Pentoxifylline—systemic scleroderma	0.000675	0.00326	CcSEcCtD
Cefotaxime—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000672	0.00325	CcSEcCtD
Cefotaxime—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000672	0.00325	CcSEcCtD
Cefotaxime—Arrhythmia—Leflunomide—systemic scleroderma	0.000667	0.00322	CcSEcCtD
Cefotaxime—Agranulocytosis—Lisinopril—systemic scleroderma	0.000667	0.00322	CcSEcCtD
Cefotaxime—Discomfort—Captopril—systemic scleroderma	0.000664	0.00321	CcSEcCtD
Cefotaxime—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000657	0.00317	CcSEcCtD
Cefotaxime—Anaphylactic shock—Captopril—systemic scleroderma	0.000644	0.00311	CcSEcCtD
Cefotaxime—Hepatitis—Lisinopril—systemic scleroderma	0.000642	0.0031	CcSEcCtD
Cefotaxime—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000639	0.00309	CcSEcCtD
Cefotaxime—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000637	0.00308	CcSEcCtD
Cefotaxime—Vaginal inflammation—Methotrexate—systemic scleroderma	0.000635	0.00307	CcSEcCtD
Cefotaxime—Shock—Captopril—systemic scleroderma	0.000634	0.00306	CcSEcCtD
Cefotaxime—Thrombocytopenia—Captopril—systemic scleroderma	0.000631	0.00305	CcSEcCtD
Cefotaxime—Pain—Mometasone—systemic scleroderma	0.000627	0.00303	CcSEcCtD
Cefotaxime—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000626	0.00302	CcSEcCtD
Cefotaxime—Malaise—Azathioprine—systemic scleroderma	0.000621	0.003	CcSEcCtD
Cefotaxime—Leukopenia—Azathioprine—systemic scleroderma	0.000616	0.00298	CcSEcCtD
Cefotaxime—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000616	0.00298	CcSEcCtD
Cefotaxime—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000611	0.00295	CcSEcCtD
Cefotaxime—Erythema multiforme—Lisinopril—systemic scleroderma	0.000607	0.00293	CcSEcCtD
Cefotaxime—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000603	0.00292	CcSEcCtD
Cefotaxime—Pruritus—Pentoxifylline—systemic scleroderma	0.000601	0.0029	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Mometasone—systemic scleroderma	0.0006	0.0029	CcSEcCtD
Cefotaxime—Vaginal infection—Methotrexate—systemic scleroderma	0.000599	0.00289	CcSEcCtD
Cefotaxime—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000596	0.00288	CcSEcCtD
Cefotaxime—Angioedema—Leflunomide—systemic scleroderma	0.000594	0.00287	CcSEcCtD
Cefotaxime—Malaise—Leflunomide—systemic scleroderma	0.000587	0.00283	CcSEcCtD
Cefotaxime—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00282	CcSEcCtD
Cefotaxime—Leukopenia—Leflunomide—systemic scleroderma	0.000582	0.00281	CcSEcCtD
Cefotaxime—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000581	0.00281	CcSEcCtD
Cefotaxime—Body temperature increased—Mometasone—systemic scleroderma	0.00058	0.0028	CcSEcCtD
Cefotaxime—Abdominal pain—Mometasone—systemic scleroderma	0.00058	0.0028	CcSEcCtD
Cefotaxime—Discomfort—Azathioprine—systemic scleroderma	0.000579	0.0028	CcSEcCtD
Cefotaxime—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000576	0.00278	CcSEcCtD
Cefotaxime—Arrhythmia—Lisinopril—systemic scleroderma	0.000573	0.00277	CcSEcCtD
Cefotaxime—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000565	0.00273	CcSEcCtD
Cefotaxime—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000562	0.00272	CcSEcCtD
Cefotaxime—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000562	0.00272	CcSEcCtD
Cefotaxime—Malaise—Mycophenolic acid—systemic scleroderma	0.00056	0.0027	CcSEcCtD
Cefotaxime—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000555	0.00268	CcSEcCtD
Cefotaxime—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00055	0.00266	CcSEcCtD
Cefotaxime—Discomfort—Leflunomide—systemic scleroderma	0.000547	0.00264	CcSEcCtD
Cefotaxime—Vomiting—Pentoxifylline—systemic scleroderma	0.00054	0.00261	CcSEcCtD
Cefotaxime—Convulsion—Mycophenolic acid—systemic scleroderma	0.000538	0.0026	CcSEcCtD
Cefotaxime—Rash—Pentoxifylline—systemic scleroderma	0.000536	0.00259	CcSEcCtD
Cefotaxime—Dermatitis—Pentoxifylline—systemic scleroderma	0.000535	0.00259	CcSEcCtD
Cefotaxime—Headache—Pentoxifylline—systemic scleroderma	0.000532	0.00257	CcSEcCtD
Cefotaxime—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000531	0.00256	CcSEcCtD
Cefotaxime—Feeling abnormal—Captopril—systemic scleroderma	0.000531	0.00256	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Captopril—systemic scleroderma	0.000527	0.00254	CcSEcCtD
Cefotaxime—Discomfort—Mycophenolic acid—systemic scleroderma	0.000522	0.00252	CcSEcCtD
Cefotaxime—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00052	0.00251	CcSEcCtD
Cefotaxime—Pruritus—Mometasone—systemic scleroderma	0.000519	0.00251	CcSEcCtD
Cefotaxime—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000519	0.0025	CcSEcCtD
Cefotaxime—Angioedema—Lisinopril—systemic scleroderma	0.000511	0.00247	CcSEcCtD
Cefotaxime—Body temperature increased—Captopril—systemic scleroderma	0.000509	0.00246	CcSEcCtD
Cefotaxime—Abdominal pain—Captopril—systemic scleroderma	0.000509	0.00246	CcSEcCtD
Cefotaxime—Nausea—Pentoxifylline—systemic scleroderma	0.000505	0.00244	CcSEcCtD
Cefotaxime—Malaise—Lisinopril—systemic scleroderma	0.000504	0.00243	CcSEcCtD
Cefotaxime—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000502	0.00243	CcSEcCtD
Cefotaxime—Diarrhoea—Mometasone—systemic scleroderma	0.000502	0.00242	CcSEcCtD
Cefotaxime—Leukopenia—Lisinopril—systemic scleroderma	0.0005	0.00242	CcSEcCtD
Cefotaxime—Shock—Mycophenolic acid—systemic scleroderma	0.000498	0.00241	CcSEcCtD
Cefotaxime—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000496	0.00239	CcSEcCtD
Cefotaxime—Discomfort—Lisinopril—systemic scleroderma	0.00047	0.00227	CcSEcCtD
Cefotaxime—Vomiting—Mometasone—systemic scleroderma	0.000466	0.00225	CcSEcCtD
Cefotaxime—Feeling abnormal—Azathioprine—systemic scleroderma	0.000463	0.00224	CcSEcCtD
Cefotaxime—Rash—Mometasone—systemic scleroderma	0.000462	0.00223	CcSEcCtD
Cefotaxime—Dermatitis—Mometasone—systemic scleroderma	0.000462	0.00223	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00046	0.00222	CcSEcCtD
Cefotaxime—Headache—Mometasone—systemic scleroderma	0.000459	0.00222	CcSEcCtD
Cefotaxime—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000456	0.0022	CcSEcCtD
Cefotaxime—Pruritus—Captopril—systemic scleroderma	0.000456	0.0022	CcSEcCtD
Cefotaxime—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000454	0.00219	CcSEcCtD
Cefotaxime—Pain—Leflunomide—systemic scleroderma	0.000454	0.00219	CcSEcCtD
Cefotaxime—Shock—Lisinopril—systemic scleroderma	0.000449	0.00217	CcSEcCtD
Cefotaxime—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00216	CcSEcCtD
Cefotaxime—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000447	0.00216	CcSEcCtD
Cefotaxime—Neutropenia—Prednisone—systemic scleroderma	0.000445	0.00215	CcSEcCtD
Cefotaxime—Abdominal pain—Azathioprine—systemic scleroderma	0.000444	0.00215	CcSEcCtD
Cefotaxime—Body temperature increased—Azathioprine—systemic scleroderma	0.000444	0.00215	CcSEcCtD
Cefotaxime—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000442	0.00213	CcSEcCtD
Cefotaxime—Diarrhoea—Captopril—systemic scleroderma	0.000441	0.00213	CcSEcCtD
Cefotaxime—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000438	0.00212	CcSEcCtD
Cefotaxime—Feeling abnormal—Leflunomide—systemic scleroderma	0.000437	0.00211	CcSEcCtD
Cefotaxime—Nausea—Mometasone—systemic scleroderma	0.000436	0.0021	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000434	0.0021	CcSEcCtD
Cefotaxime—Pain—Mycophenolic acid—systemic scleroderma	0.000433	0.00209	CcSEcCtD
Cefotaxime—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00205	CcSEcCtD
Cefotaxime—Urticaria—Leflunomide—systemic scleroderma	0.000422	0.00204	CcSEcCtD
Cefotaxime—Abdominal pain—Leflunomide—systemic scleroderma	0.00042	0.00203	CcSEcCtD
Cefotaxime—Body temperature increased—Leflunomide—systemic scleroderma	0.00042	0.00203	CcSEcCtD
Cefotaxime—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000417	0.00202	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000415	0.002	CcSEcCtD
Cefotaxime—Hypersensitivity—Azathioprine—systemic scleroderma	0.000414	0.002	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000414	0.002	CcSEcCtD
Cefotaxime—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000412	0.00199	CcSEcCtD
Cefotaxime—Vomiting—Captopril—systemic scleroderma	0.000409	0.00198	CcSEcCtD
Cefotaxime—Rash—Captopril—systemic scleroderma	0.000406	0.00196	CcSEcCtD
Cefotaxime—Dermatitis—Captopril—systemic scleroderma	0.000406	0.00196	CcSEcCtD
Cefotaxime—Headache—Captopril—systemic scleroderma	0.000403	0.00195	CcSEcCtD
Cefotaxime—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0004	0.00193	CcSEcCtD
Cefotaxime—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0004	0.00193	CcSEcCtD
Cefotaxime—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.0004	0.00193	CcSEcCtD
Cefotaxime—Eosinophilia—Methotrexate—systemic scleroderma	0.000394	0.0019	CcSEcCtD
Cefotaxime—Shock—Mycophenolate mofetil—systemic scleroderma	0.000393	0.0019	CcSEcCtD
Cefotaxime—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000391	0.00189	CcSEcCtD
Cefotaxime—Hypersensitivity—Leflunomide—systemic scleroderma	0.000391	0.00189	CcSEcCtD
Cefotaxime—Pain—Lisinopril—systemic scleroderma	0.00039	0.00188	CcSEcCtD
Cefotaxime—Diarrhoea—Azathioprine—systemic scleroderma	0.000385	0.00186	CcSEcCtD
Cefotaxime—Haemoglobin—Prednisone—systemic scleroderma	0.000383	0.00185	CcSEcCtD
Cefotaxime—Nausea—Captopril—systemic scleroderma	0.000383	0.00185	CcSEcCtD
Cefotaxime—Haemorrhage—Prednisone—systemic scleroderma	0.000381	0.00184	CcSEcCtD
Cefotaxime—Feeling abnormal—Lisinopril—systemic scleroderma	0.000376	0.00182	CcSEcCtD
Cefotaxime—Pruritus—Leflunomide—systemic scleroderma	0.000376	0.00181	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000373	0.0018	CcSEcCtD
Cefotaxime—Neutropenia—Methotrexate—systemic scleroderma	0.000372	0.0018	CcSEcCtD
Cefotaxime—Diarrhoea—Leflunomide—systemic scleroderma	0.000363	0.00175	CcSEcCtD
Cefotaxime—Urticaria—Lisinopril—systemic scleroderma	0.000362	0.00175	CcSEcCtD
Cefotaxime—Abdominal pain—Lisinopril—systemic scleroderma	0.000361	0.00174	CcSEcCtD
Cefotaxime—Body temperature increased—Lisinopril—systemic scleroderma	0.000361	0.00174	CcSEcCtD
Cefotaxime—Pruritus—Mycophenolic acid—systemic scleroderma	0.000358	0.00173	CcSEcCtD
Cefotaxime—Vomiting—Azathioprine—systemic scleroderma	0.000357	0.00173	CcSEcCtD
Cefotaxime—Rash—Azathioprine—systemic scleroderma	0.000354	0.00171	CcSEcCtD
Cefotaxime—Dermatitis—Azathioprine—systemic scleroderma	0.000354	0.00171	CcSEcCtD
Cefotaxime—Headache—Azathioprine—systemic scleroderma	0.000352	0.0017	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000352	0.0017	CcSEcCtD
Cefotaxime—Renal failure—Methotrexate—systemic scleroderma	0.000349	0.00169	CcSEcCtD
Cefotaxime—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000346	0.00167	CcSEcCtD
Cefotaxime—Pain—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00165	CcSEcCtD
Cefotaxime—Arrhythmia—Prednisone—systemic scleroderma	0.000341	0.00165	CcSEcCtD
Cefotaxime—Vomiting—Leflunomide—systemic scleroderma	0.000337	0.00163	CcSEcCtD
Cefotaxime—Hypersensitivity—Lisinopril—systemic scleroderma	0.000336	0.00162	CcSEcCtD
Cefotaxime—Rash—Leflunomide—systemic scleroderma	0.000335	0.00162	CcSEcCtD
Cefotaxime—Dermatitis—Leflunomide—systemic scleroderma	0.000334	0.00162	CcSEcCtD
Cefotaxime—Nausea—Azathioprine—systemic scleroderma	0.000334	0.00161	CcSEcCtD
Cefotaxime—Headache—Leflunomide—systemic scleroderma	0.000333	0.00161	CcSEcCtD
Cefotaxime—Agranulocytosis—Methotrexate—systemic scleroderma	0.000331	0.0016	CcSEcCtD
Cefotaxime—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000329	0.00159	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00158	CcSEcCtD
Cefotaxime—Pruritus—Lisinopril—systemic scleroderma	0.000323	0.00156	CcSEcCtD
Cefotaxime—Vomiting—Mycophenolic acid—systemic scleroderma	0.000322	0.00156	CcSEcCtD
Cefotaxime—Haemoglobin—Methotrexate—systemic scleroderma	0.00032	0.00155	CcSEcCtD
Cefotaxime—Rash—Mycophenolic acid—systemic scleroderma	0.000319	0.00154	CcSEcCtD
Cefotaxime—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000319	0.00154	CcSEcCtD
Cefotaxime—Haemorrhage—Methotrexate—systemic scleroderma	0.000319	0.00154	CcSEcCtD
Cefotaxime—Hepatitis—Methotrexate—systemic scleroderma	0.000319	0.00154	CcSEcCtD
Cefotaxime—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000317	0.00153	CcSEcCtD
Cefotaxime—Headache—Mycophenolic acid—systemic scleroderma	0.000317	0.00153	CcSEcCtD
Cefotaxime—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00153	CcSEcCtD
Cefotaxime—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00153	CcSEcCtD
Cefotaxime—Nausea—Leflunomide—systemic scleroderma	0.000315	0.00152	CcSEcCtD
Cefotaxime—Diarrhoea—Lisinopril—systemic scleroderma	0.000312	0.00151	CcSEcCtD
Cefotaxime—Ill-defined disorder—Prednisone—systemic scleroderma	0.000308	0.00149	CcSEcCtD
Cefotaxime—Angioedema—Prednisone—systemic scleroderma	0.000303	0.00147	CcSEcCtD
Cefotaxime—Erythema multiforme—Methotrexate—systemic scleroderma	0.000301	0.00146	CcSEcCtD
Cefotaxime—Nausea—Mycophenolic acid—systemic scleroderma	0.000301	0.00145	CcSEcCtD
Cefotaxime—Malaise—Prednisone—systemic scleroderma	0.000299	0.00145	CcSEcCtD
Cefotaxime—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000294	0.00142	CcSEcCtD
Cefotaxime—Vomiting—Lisinopril—systemic scleroderma	0.00029	0.0014	CcSEcCtD
Cefotaxime—Rash—Lisinopril—systemic scleroderma	0.000288	0.00139	CcSEcCtD
Cefotaxime—Convulsion—Prednisone—systemic scleroderma	0.000288	0.00139	CcSEcCtD
Cefotaxime—Dermatitis—Lisinopril—systemic scleroderma	0.000287	0.00139	CcSEcCtD
Cefotaxime—Headache—Lisinopril—systemic scleroderma	0.000286	0.00138	CcSEcCtD
Cefotaxime—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00137	CcSEcCtD
Cefotaxime—Discomfort—Prednisone—systemic scleroderma	0.000279	0.00135	CcSEcCtD
Cefotaxime—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000273	0.00132	CcSEcCtD
Cefotaxime—Nausea—Lisinopril—systemic scleroderma	0.000271	0.00131	CcSEcCtD
Cefotaxime—Anaphylactic shock—Prednisone—systemic scleroderma	0.000271	0.00131	CcSEcCtD
Cefotaxime—Shock—Prednisone—systemic scleroderma	0.000267	0.00129	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000257	0.00124	CcSEcCtD
Cefotaxime—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00123	CcSEcCtD
Cefotaxime—Rash—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00122	CcSEcCtD
Cefotaxime—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00122	CcSEcCtD
Cefotaxime—Headache—Mycophenolate mofetil—systemic scleroderma	0.00025	0.00121	CcSEcCtD
Cefotaxime—Malaise—Methotrexate—systemic scleroderma	0.00025	0.00121	CcSEcCtD
Cefotaxime—Leukopenia—Methotrexate—systemic scleroderma	0.000248	0.0012	CcSEcCtD
Cefotaxime—Convulsion—Methotrexate—systemic scleroderma	0.00024	0.00116	CcSEcCtD
Cefotaxime—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00115	CcSEcCtD
Cefotaxime—Discomfort—Methotrexate—systemic scleroderma	0.000233	0.00113	CcSEcCtD
Cefotaxime—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000226	0.00109	CcSEcCtD
Cefotaxime—Feeling abnormal—Prednisone—systemic scleroderma	0.000223	0.00108	CcSEcCtD
Cefotaxime—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000222	0.00107	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000222	0.00107	CcSEcCtD
Cefotaxime—Urticaria—Prednisone—systemic scleroderma	0.000215	0.00104	CcSEcCtD
Cefotaxime—Abdominal pain—Prednisone—systemic scleroderma	0.000214	0.00103	CcSEcCtD
Cefotaxime—Body temperature increased—Prednisone—systemic scleroderma	0.000214	0.00103	CcSEcCtD
Cefotaxime—Hypersensitivity—Prednisone—systemic scleroderma	0.0002	0.000964	CcSEcCtD
Cefotaxime—Pain—Methotrexate—systemic scleroderma	0.000194	0.000935	CcSEcCtD
Cefotaxime—Pruritus—Prednisone—systemic scleroderma	0.000192	0.000926	CcSEcCtD
Cefotaxime—Feeling abnormal—Methotrexate—systemic scleroderma	0.000187	0.000901	CcSEcCtD
Cefotaxime—Diarrhoea—Prednisone—systemic scleroderma	0.000185	0.000895	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000185	0.000894	CcSEcCtD
Cefotaxime—Urticaria—Methotrexate—systemic scleroderma	0.00018	0.000869	CcSEcCtD
Cefotaxime—Abdominal pain—Methotrexate—systemic scleroderma	0.000179	0.000864	CcSEcCtD
Cefotaxime—Body temperature increased—Methotrexate—systemic scleroderma	0.000179	0.000864	CcSEcCtD
Cefotaxime—Vomiting—Prednisone—systemic scleroderma	0.000172	0.000832	CcSEcCtD
Cefotaxime—Rash—Prednisone—systemic scleroderma	0.000171	0.000825	CcSEcCtD
Cefotaxime—Dermatitis—Prednisone—systemic scleroderma	0.000171	0.000824	CcSEcCtD
Cefotaxime—Headache—Prednisone—systemic scleroderma	0.00017	0.00082	CcSEcCtD
Cefotaxime—Hypersensitivity—Methotrexate—systemic scleroderma	0.000167	0.000806	CcSEcCtD
Cefotaxime—Nausea—Prednisone—systemic scleroderma	0.000161	0.000777	CcSEcCtD
Cefotaxime—Pruritus—Methotrexate—systemic scleroderma	0.00016	0.000774	CcSEcCtD
Cefotaxime—Diarrhoea—Methotrexate—systemic scleroderma	0.000155	0.000748	CcSEcCtD
Cefotaxime—Vomiting—Methotrexate—systemic scleroderma	0.000144	0.000695	CcSEcCtD
Cefotaxime—Rash—Methotrexate—systemic scleroderma	0.000143	0.00069	CcSEcCtD
Cefotaxime—Dermatitis—Methotrexate—systemic scleroderma	0.000143	0.000689	CcSEcCtD
Cefotaxime—Headache—Methotrexate—systemic scleroderma	0.000142	0.000685	CcSEcCtD
Cefotaxime—Nausea—Methotrexate—systemic scleroderma	0.000134	0.00065	CcSEcCtD
